|
|
|
| home > white papers > Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models - DrugDev |
|
|
 WHITE PAPERS |
|
DrugDev
|
|
Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models
|
|
For the last 20 years, pharmaceutical companies have turned to a variety
of clinical outsourcing solutions to reduce costs and improve
timelines, enabling them to focus on their core value of research and
development. In today’s tightly competitive market, companies are
constantly striving for ways to further cut costs and reduce study
startup cycle times, while maintaining quality.
One of the key
cost factors in global R&D spending, estimated at around $102
billion per Kalorama market research, is the cost of conducting clinical
trials. CRO’s, which account for about 30% of the total R&D
spending, have risen to the challenge of the clinical, technical and
administrative management of these trials. But some pharmaceutical
companies question how much control to relinquish to vendor partners,
especially in the legal arena, due to potential ramifications.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
FlyPharma Conference Europe: New dates and location announced
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022. Taking
place in Leipzig, Germany on 19-21 September, FlyPharma Europe will
bring together a global audience of (bio)pharma logistics professionals
to discuss and debate the latest supply chain challenges and industry
best practices.
More info >> |
|
 |
White Papers |
 |
|
Contemporary Issues in Comparator Trial Supply
Clinigen CTS
As trial design and execution becomes ever-more complex, initiatives to
adapt, increase efficiency and control costs without compromising
quality become paramount. Here, Clinigen CTS covers the broad issues and
summarises the responses our industry is making in this increasingly
demanding landscape.
More info >> |
|
|
|
